Search - tctmd.com

Displaying 701 - 720 of 7326

Sort: Relevancy | Date

Presentation TCT 2024

TCT 970: Cost and Healthcare Utilization by Age, Sex, and Race in the Years Leading Up to a Severe or Clinically Significant Status for Patients With Tricuspid Regurgitation

Presenter: Colin Barker

October 29, 2024

Presentation TCT 2024

Results of DanGer Shock: Risks and Benefits of MCS for Cardiogenic Shock Put Into Perspective

Presenter: Jacob Moeller

October 29, 2024

Presentation TCT 2024

Ways in Which DanGer Will and Will Not Influence Clinical Practice in the EU

Presenter: Jose Henriques

October 29, 2024

Presentation TCT 2024

A Mandate to Generate Evidence for the Use of Temporary Support Devices in Decompensated Chronic Heart Failure Shock

Presenter: Jane Wilcox

October 29, 2024

Presentation TCT 2024

Latest Advancements in the Best CLI-Basil Patient Journey

Presenter: Matthew Menard

October 29, 2024

Presentation TCT 2024

Ways in which DanGer Will and Will Not Influence Clinical Practice in the US

Presenter: David Morrow

October 29, 2024

Presentation TCT 2024

TCT 171: Baseline Invasive Hemodynamics and Clinical Outcomes in Transcatheter Tricuspid Valve Replacement? Using the EVOQUE System

Presenter: Omar Abdelhai

October 29, 2024

Presentation TCT 2024

TCT 815: The Impact of Daylight Savings Time on Clinical Outcomes in Patients With Acute Myocardial Infarction: Insights From the NCDR CathPCI Registry

Presenter: Jennifer Rymer

October 29, 2024

Presentation TCT 2024

TCT 426: One-Year Clinical Outcome of Prasugrel Monotherapy After PCI for Chronic Coronary Syndrome in Japanese Population

Presenter: KOTARO MIYASHITA

October 29, 2024

Presentation TCT 2024

TCT 832: Impact of Coronary Artery Disease and Revascularization on Clinical and Health Status Outcomes After TAVR: Results From the STS/ACC TVT Registry

Presenter: Yasser Sammour

October 29, 2024

Presentation TCT 2024

TCT 262: Clinical and Hemodynamic Predictors of Stabilization and Associated Complications in Cardiogenic Shock Patients Supported With Impella 5.5

Presenter: Shashank Sinha

October 29, 2024

Presentation TCT 2024

TCT 427: Comparison of Clinical Outcomes Between Second Generation Zotarolimus- Versus Everolimus-Eluting Stents up to 10-Year Follow-up

Presenter: Woo Jin Ahn

October 29, 2024

Presentation TCT 2024

Clinical Phenotypes of TR Patients: Same but Different?

Presenter: Laura Davidson

October 29, 2024

Presentation TCT 2024

Best CLI Medical Therapy Subgroup

Presenter: Matthew Menard

October 29, 2024

Presentation TCT 2024

How Can Clinical Trials Mobilize the Diversity Efforts?

Presenter: Roxana Mehran

October 29, 2024

Presentation TCT 2024

Debate Pro: RDN Could Be Useful for the Majority of Patients with Uncontrolled HTN

Presenter: Raymond Townsend

October 29, 2024

Presentation TCT 2024

Debate Con: RDN Will Ultimately Be a Niche Therapy

Presenter: Andrew Sharp

October 29, 2024

Presentation TCT 2024

Debate Con: Predictors of Efficacy are Sorely Needed in the RDN Space!

Presenter: Eric Secemsky

October 29, 2024

Presentation TCT 2024

Debate Pro: Predictors of Efficacy are Not Needed for Most Patients

Presenter: Michael Weber

October 29, 2024

Presentation TCT 2024

How to Set Up Your RDN Hypertension Program: Team Members and Patient Flow

Presenter: Michael Bloch

October 29, 2024

Advertisement

TCT 970: Cost and Healthcare Utilization by Age, Sex, and Race in the Years Leading Up to a Severe or Clinically Significant Status for Patients With Tricuspid Regurgitation

Results of DanGer Shock: Risks and Benefits of MCS for Cardiogenic Shock Put Into Perspective

Ways in Which DanGer Will and Will Not Influence Clinical Practice in the EU

A Mandate to Generate Evidence for the Use of Temporary Support Devices in Decompensated Chronic Heart Failure Shock

Latest Advancements in the Best CLI-Basil Patient Journey

Ways in which DanGer Will and Will Not Influence Clinical Practice in the US

TCT 171: Baseline Invasive Hemodynamics and Clinical Outcomes in Transcatheter Tricuspid Valve Replacement? Using the EVOQUE System

TCT 815: The Impact of Daylight Savings Time on Clinical Outcomes in Patients With Acute Myocardial Infarction: Insights From the NCDR CathPCI Registry

TCT 426: One-Year Clinical Outcome of Prasugrel Monotherapy After PCI for Chronic Coronary Syndrome in Japanese Population

TCT 832: Impact of Coronary Artery Disease and Revascularization on Clinical and Health Status Outcomes After TAVR: Results From the STS/ACC TVT Registry

TCT 262: Clinical and Hemodynamic Predictors of Stabilization and Associated Complications in Cardiogenic Shock Patients Supported With Impella 5.5

TCT 427: Comparison of Clinical Outcomes Between Second Generation Zotarolimus- Versus Everolimus-Eluting Stents up to 10-Year Follow-up

Clinical Phenotypes of TR Patients: Same but Different?

Best CLI Medical Therapy Subgroup

How Can Clinical Trials Mobilize the Diversity Efforts?

Debate Pro: RDN Could Be Useful for the Majority of Patients with Uncontrolled HTN

Debate Con: RDN Will Ultimately Be a Niche Therapy

Debate Con: Predictors of Efficacy are Sorely Needed in the RDN Space!

Debate Pro: Predictors of Efficacy are Not Needed for Most Patients

How to Set Up Your RDN Hypertension Program: Team Members and Patient Flow

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content